Alexander N. Fedenko, MD

Associate Professor of Clinical Pathology

Is this your profile? Click to edit

Publications

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma. Cancer Res Commun. 2025 02 01; 5(2):358-368.. View in PubMed
Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review. Front Oncol. 2022; 12:953908.. View in PubMed
Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman. Rare Tumors. 2022; 14:20363613221110836.. View in PubMed
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022 01; 33(1):20-33.. View in PubMed
Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021 12; 32(12):1520-1536.. View in PubMed
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021 11; 32(11):1348-1365.. View in PubMed
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. ESMO Open. 2021 06; 6(3):100170.. View in PubMed
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med. 2021 04; 10(8):2645-2659.. View in PubMed
Bizarre parosteal osteochondromatous proliferation: Rare case affecting distal ulna and review of literature. Clin Imaging. 2021 Jan; 69:233-237.. View in PubMed
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial. JAMA. 2020 04 07; 323(13):1266-1276.. View in PubMed

Alexander N. Fedenko, MD

Publications

Similar People